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doi:10.1Objective: Pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries is
a complex lesion with a high rate of natural attrition. We evaluated the outcomes of our strategy of unifocalization
in the management of these patients.
Methods: From 1989 to 2008, 216 patients entered a pathway aiming for complete repair by unifocalizing major
aortopulmonary arteries to a right ventricle-pulmonary artery conduit with ventricular septal defect closure.
Where ventricular septation was not possible, definitive repair was considered to include pulmonary artery recon-
struction and a right ventricle-pulmonary artery conduit or systemic shunt. Native pulmonary artery morphology
was classified into confluent intrapericardial (n ¼ 139), confluent intrapulmonary (n ¼ 51), and nonconfluent in-
trapulmonary (n ¼ 26).
Results:A total of 203 patients (85%) had definitive repair at a median age of 2.0 years. There was no statistically
significant difference in survival after complete repair among the 3 morphologic pulmonary artery groups
(P ¼ .18). A total of 132 patients (56%) had complete repair with ventricular septal defect closure, as a single
procedure in 111 patients and a staged procedure in 21 patients. Focalization of major aortopulmonary collateral
arteries with proven long-term patency with the right ventricle was associated with a survival benefit compared
with 14 patients in whom unifocalization was not possible and who had only systemic shunts. Overall survival
was 89% at 3 years after definitive repair. During follow-up, 190 patients required 196 catheter reinterventions
and 60 surgical reinterventions.
Conclusion: By using a strategy of unifocalization, intrapericardial pulmonary artery reconstruction, and right
ventricle-pulmonary artery conduit, excellent long-term survival can be achieved in this group of patients
even in the absence of native intrapericardial pulmonary arteries. (J Thorac Cardiovasc Surg 2009;138:1269-75)Supplemental material is available online.Pulmonary atresia with ventricular septal defect (VSD) and
major aortopulmonary collateral arteries (MAPCAs) is
a complex lesion that is estimated to occur in 10 of
100,000 liveborn infants and that has a high rate of natural
attrition.1,2 Until recently, only a small proportion of infants
with this condition would ultimately undergo complete
repair, and the outcomes after surgical intervention
were disappointing,3-5 with an estimated 20% chance of
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The Journal of Thoracic and CarIn this group of patients, pulmonary arterial blood flow is
providedbyMAPCAs,whichvary in number and origin,6-8 to-
gether with the heterogeneous presence of native central PAs.
Themanagement ofMAPCAs and their incorporation into any
definitive repair remains controversial. Without intervention,
MAPCAs may stenose and occlude or alternatively induce
pulmonary vascular disease as a result of overperfusion.
We believe a key determinant of long-term success is to
maximize recruitment of lung segments, and definitive
repair should include mobilization and incorporation of
native MAPCAs into a reconstructed central and peripheral
pulmonary arterial tree, closure of the VSD, and a right ven-
tricle-pulmonary artery (RV-PA) conduit to establish conti-
nuity between the PA confluence and the RV. This may be
achieved by single or multiple stages via sternotomy or
thoracotomies to perform mobilization of MAPCAs,
augmentation of hilar vessels, or systemic-to-pulmonary
shunts. Such a strategy has been successfully used,9 yet is
contrary to clinical practice undertaken by others.10
There remains little evidence that an aggressive surgical
approach in this particular patient group confers any
long-term survival benefits or functional advantage overdiovascular Surgery c Volume 138, Number 6 1269
Congenital Heart Disease Davies et al
C
H
D12Abbreviations and Acronyms70CI ¼The Joconfidence intervalMAPCAs ¼ major aortopulmonary collateral
arteriesOR ¼ odds ratio
RV-PA ¼ right ventricle-pulmonary artery
VSD ¼ ventricular septal defectshunted patients, and most published data are limited to
small surgical series with follow-up approaching 10
years. The objectives of the current study were to evaluate
the outcomes of our policy that emphasizes MAPCA
unifocalization together with intrahilar and intrapericardial
PA reconstruction.
MATERIALS AND METHODS
The National Research Ethics Service, United Kingdom, considered this
study to be a service evaluation and therefore did not require review by the
National Health Service Research Ethics Committee. The data of all patients
with pulmonary atresia, VSD, and MAPCAs who underwent surgical inter
vention at Birmingham Children’s Hospital, Birmingham, United King
dom, between January 1, 1989, and July 31, 2008, were reviewed.
Patients with other intracardiac pathologies accompanied by MAPCAs
were excluded from the study. A total of 237 patients entered a treatment
pathway aiming for complete repair by unifocalizing major aortopulmonary
arteries to an RV PA conduit with VSD closure. When ventricular septation
was not possible, definitive repair was considered to include PA reconstruc
tion and a limiting RV PA conduit or systemic pulmonary shunt. Of these
237 patients, complete follow up data were available for 216 (120 female),
and this cohort was used for analysis.
Assessment
Echocardiographic assessment was supplemented by cardiac catheter
ization to delineate the pulmonary blood supply and the characteristics
of the MAPCAs. Patients were classified into 3 morphologic subgroups
according to the presence or absence of confluent native PAs within
the pericardium and at the hilum of the lung.11 This spectrum extends
in increasing order of complexity from confluent intrapericardial vessels,
through absent intrapericardial but confluent intrapulmonary vessels, to
absent intrapericardial and nonconfluent intrapulmonary vessels. The rel
ative importance of each MAPCA was considered with a view to incor
porating them into a definitive repair to maximize recruitment of at
least 15 individual lung segments. The number of MAPCAs was assessed,
and the patients were grouped categorically into less than 5 or more than
5 for the purposes of analysis.
Surgical Approach
The technical aspects of surgical intervention facilitated by hypothermic
cardiopulmonary bypass with intermittent circulatory arrest have been
described11,12 and share several common features with techniques reported
by other centers.9,13 17
Follow-up
Dates of definitive surgery were chosen as a common time point from
which to derive follow up for all patients. Reintervention was defined as
the time from definitive surgery to the first surgical or catheter based
intervention because we considered that after such interventions the naturalurnal of Thoracic and Cardiovascular Surhistories of individual patients were considered to be sufficiently disparate
to preclude further useful analysis on a cohort basis.
Statistics
Data are presented as median with interquartile range or mean standard
deviation. Survival analysis was performed by the Kaplan Meier method,
and data were compared using log rank and Wilcoxon tests. Multifactor
analysis of risk factors for survival or death was performed by Cox propor
tional hazards regression. Factors included in the analysis were age at defin
itive surgery, gender, DiGeorge syndrome, native PA morphology, the
number of MAPCAs, prior surgery at other centers, prior recruitment
procedures, or creation of a central shunt or a peripheral shunt. Analyses
were performed with SPSS 17.0 (SPSS UK Ltd, Woking, UK).RESULTS
Patient Characteristics
A total of 216 patients (120 female) were identified.
Native PA morphology was classified into confluent intra-
pericardial (n ¼ 139), confluent intrapulmonary (n ¼ 51),
and nonconfluent intrapulmonary (n ¼ 26). A total of 123
patients had less than 5 MAPCAs, and 24 patients had
more than 5 MAPCAs (69 patients missing information).
Twenty-five patients (11%) had clinically overt DiGeorge
syndrome; genetic testing for 22q11 deletion was per-
formed selectively after informed parental consent was
obtained. Before definitive surgery, 50 patients underwent
unilateral (n ¼ 14) or bilateral (n ¼ 36) MAPCA recruit-
ment procedures. Sixty-one patients had expanded polyte-
trafluoroethylene modified Blalock-Taussig or end-to-side
central ‘‘Mee’’ systemic-pulmonary shunts. Sixteen
patients had undergone procedures at other institutions
before referral.Surgical Algorithm
Median age at definitive surgery was 2.0 years (inter-
quartile range, 0.8 5.5 years). Median follow-up time
was 2.3 years (interquartile range, 0.1 6.7 years). There
were 13 early (6%) and 13 late (6%) deaths. Establish-
ment of RV-PA continuity with a valved conduit and
VSD closure was possible in 158 patients (73%): single-
stage basis in 104 patients (48%) and multiple-stage basis
in 54 patients (25%). At last follow-up, the VSD remained
open in 21 patients with an RV-PA conduit. For 37 pa-
tients, the definitive procedure was PA reconstruction
with systemic-pulmonary shunting without RV-PA conduit
or VSD closure (Figure 1).Follow-up
Overall survival was 89% at 3 years. Figure 2 shows the
changing distribution of patients by outcome category after
definitive surgery. Multifactor analysis of risk factors
for survival or death performed by stepwise Cox propor-
tional hazards regression selected only RV-PA conduit as
statistically significant (P< .05). Single-factor analyses for
survival are shown in Table 1.gery c December 2009
FIGURE 1. Flow chart summarizing the surgical treatment of 216 patients. MAPCA, Major aortopulmonary collateral arteries; PA, pulmonary artery; RV,
right ventricle; VSD, ventricular septal defect.
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By taking the cohort as a whole, no significant differences
in the likelihood of survival were identified in patients after
definitive surgery irrespective of native PA morphology
(Figure 3). By comparing nonconfluent intrapulmonary
and confluent intrapericardial native PAs, the 2 morphologic
extremes of the spectrum, there was a nonsignificant
tendency to increased risk of death in the former group
(odds ratio [OR], 2.46; 95% confidence interval [CI],
0.94 6.47; P ¼ .07) By looking closer at the subset of pa-
tients who had complete repair including RV-PA conduit
and VSD closure, there were significant differences in
survival in regard to native PA morphology (P ¼ .01).FIGURE 2. Scatter plot showing distribution of patients by outcome
category after definitive surgery.Achievement of Complete Repair
As is evident from the results of survival factor analysis in
Table 1, when considering factors in isolation there is little to
choose between the presence of an RV-PA conduit or VSD
closure as factors associated with survival, but clearly they
are strongly interrelated variables. The presence of an RV-
PA conduit was associated with improved survival com-
pared with systemic-pulmonary shunting alone (OR, 0.41;
95% CI, 0.17 0.97; P ¼ .04). In all patients, VSD closure
was protective against death (OR, 0.44; 95% CI, 0.20
0.98; P ¼ .04) (Figure 4).
Of the3potential combinationsofVSDandRV-PAconduit
status, the results show that achieving a complete repair with
a septated heart and an RV-PA conduit confers a survivalThe Journal of Thoracic and Caradvantage compared with patients with a shunted circulation
with neither VSD closure nor RV-PA conduit (OR, 0.38;
95%CI, 0.16 0.92;P¼ .03) (Figure 5). Therewere no signif-
icant differences in survival between those patients who had
their VSD closed on a single- or multiple-stage basis (OR,
0.57; 95% CI, 0.26 1.23; P ¼ .15) (Figure 6).Reintervention
During the follow-up period, 190 patients underwent
196 therapeutic catheter and 60 surgical reinterventionsdiovascular Surgery c Volume 138, Number 6 1271
TABLE 1. Single-factor survival analysis for death, years to death, or
end of follow-up
Factor OR 95% CI P value
Age at surgery y 0.99 0.91 1.09 .92
Gender Male vs female 1.09 0.50 2.35 .83
DiGeorge Yes vs no 0.12 0.03 0.48 .05
Previous intervention
at other center
Yes vs no 1.49 1.35 6.30 .61
Previous shunt Yes vs no 1.02 0.43 2.43 .96
Any recruitment Yes vs no 1.69 0.68 4.2 .26
RV PA conduit Yes vs no 0.41 0.17 0.97 .04
VSD/RV PA conduit
status
Open/conduit vs open 0.64 0.17 2.5 .52
Closed/conduit vs
open
0.38 0.16 0.92 .03
1 stage 1 stage vs multistage 0.57 0.26 1.23 .15
VSD closed Closed vs open 0.44 0.20 0.98 .04
VSD by stage Closed/multistage vs
open
0.56 0.21 1.48 .24
Closed/1 stage vs open 0.38 0.15 0.93 .03
Pulmonary atresia
morphologic group
Confluent
intrapulmonary
vs confluent
intrapericardial
1.53 0.61 3.83 .37
Nonconfluent
pulmonary
vs confluent
intrapericardial
2.46 0.94 6.47 .07
OR, Odds ratio; CI, confidence interval; VSD, ventricular septal defect; RV-PA, right
ventricle-pulmonary artery. Stepwise analysis selected only RV-PA conduit for
multifactor analysis; therefore, these data are not included because the result is already
in the single-factor column.
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catheter, and 49 patients had further surgery, with 9 patients
having more than 1 surgical reintervention. Single-factor
analysis showed that definitive surgery at a younger age
(OR, 0.95; 95% CI, 0.90 1.00; P ¼ .05) and nonconfluent
intrapulmonary arteries (OR, 1.68; 95% CI, 1.03 2.73;
P ¼ .04) were associated with increased reintervention.
Only age at surgery was selected for multifactor analysis
with other factors not adding extra association at the P
less than .05 level.FIGURE 3. Kaplan Meier estimated survival of all patients after definitive
surgery according to native PA morphology.
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This work adds to the increasing body of evidence that
children with pulmonary atresia VSDMAPCAs can achieve
excellent outcomes by using an approach that emphasizes
maximal recruitment of pulmonary vasculature and estab-
lishment of RV-PA continuity. These benefits are also
applicable to those lacking intrapericardial native PAs, a sub-
group who may have previously been declined surgery.
As popularized byMee, the principle of recruiting pulmo-
nary parenchyma by unifocalizingMAPCAs to a hilar mani-
fold has been developed. Contemporary series using this
approach in pulmonary atresia VSD have reported favorable
outcomes.11 There remains, however, limited long-term
follow-up data on cohorts of patients treated in this way.
Assessment of Native Pulmonary Artery Anatomy
Extensive central/intrapericardial PA reconstruction is
a key feature of our approach, and we have shown that na-
tive PA morphology is not a significant determinant of death
after definitive repair.
Other groups18 have used surrogates for adequacy of
pulmonary blood supply, including the McGoon ratio and
Nakata index, but we have not found this to be useful.11
We prefer to use a practical classification system adapted
from one originally proposed by Tchervenkov and Roy.19
In our own clinical experience, we identified and classified
patients into 1 of 3 groups according to intrapericardial
and hilar vessels.11 We rely on subjective assessment of
angiographic images and aim to recruit 1.5 lungs or 15 bron-
chopulmonary segments using a combination of native hilar
vessels and incorporating MAPCAs where appropriate.
Initial management of the right ventricular outflow tract
has evolved over time to favor reconstruction over the use
of systemic-to-pulmonary shunts that others have shown to
be associated with increased mortality independently of
other factors.14,20 The reasons for this are unclear but mayFIGURE 4. Kaplan Meier estimated survival of all patients after definitive
surgery according to VSD status. VSD, Ventricular septal defect.
gery c December 2009
FIGURE 5. Kaplan Meier estimated survival of all patients after definitive
surgery according to VSD and RV PA conduit status.
FIGURE 6. Kaplan Meier estimated survival of all patients after definitive
surgery according to VSD and whether VSD closure was achieved by
1 stage or multistage repair.
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parenchyma.
Achievement of ‘‘Complete’’ Definitive Repair
Other groups consider the natural history of MAPCAs to
be sufficiently unfavorable,10 such that they avoid incorpo-
rating them into any definitive correction. However, this ap-
proach risks suboptimal segmental perfusion and depends
on the optimistic hope that the native intrapulmonary vascu-
lature will collateralize sufficiently. The assumption that
MAPCAs occlude or lack growth potential is based on a re-
view of historical angiographic images that may be flawed.10
Furthermore, advocates of an early central shunt before
a ‘‘definitive’’ repair without incorporating MAPCAs also
risk excluding a significant number of patients from what
we would consider prognostically beneficial surgery. By
definition, a central shunt is only possible in the presence
of intrapericardial PAs, thereby excluding patients without
the prerequisite luminal patency and continuity.
We believe a key determinant of long-term success is to
maximize recruitment of lung segments at an early age,
incorporating MAPCAs where necessary, and to establish
RV-PA continuity. The current report supports this philoso-
phy. By emphasizing intervention at an early age, problems
such as stenosis and occlusion that accompany chronic
exposure of MAPCAs to systemic arterial pressure can be
avoided, irrespective of the vessels’ embryologic origin.21,22
Ventricular Septal Defect Closure Confers a Survival
Advantage Irrespective of Single or Multiple Stages
The establishment of the RV-PA continuity with a valved
conduit is protective, as is VSD closure, be it on a single- or
multiple-stage basis. VSD closure was undertaken by single
stage in 104 patients (48%) and multiple stages in 54
patients (25%), and was protective (OR, 0.85; 95% CI,
0.56 1.29; P ¼ .56) compared with leaving the VSD
open. There was no significant survival advantage of sin-
gle-stage VSD closure over multiple-stage closure; thus, as
long as the VSD is closed, it seems not to matter if it is per-
formed in a single stage or multiple stages. This was clarified
by using a compound of the potential combinations of uni-The Journal of Thoracic and Carfocalizing a PA supply to the RV with or without VSD clo-
sure. The results demonstrate that achieving a septated heart
with an RV-PA conduit had a survival advantage over
a shunted circulation.
In addition, delayed VSD closure at a later stage was
not associated with an increased risk of death compared
with primary 1-stage repair. This lack of a significant dif-
ference in survival between groups in whom VSDs were
closed initially or at a later stage is reassuring; if this
step is omitted because of initial operative considerations,
there does not seem to be a penalty associated with later
closure.
Limitations
This is a retrospective surgical series. No accurate account
could be made for patients who were reviewed but then did
not subsequently undergo surgery. Unfortunately, we do not
have access to exercise testing facilities to obtain an
objective record of patients’ functional status.
CONCLUSIONS
By using a strategy of unifocalization, intrapericardial PA
reconstruction, and RV-PA conduit, excellent long-term sur-
vival can be achieved in patients with pulmonary atresia
VSDMAPCAs even in the absence of native intrapericardial
PAs. MAPCAs are there to be recruited, not ignored. There
remains an ongoing requirement for reintervention.
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Dr Yves d’Udekem (Melbourne, Australia). We reviewed all
the results with Christian Brizard, and all the comments and ques
tions were discussed. What is your median time of follow up?
Dr Mussa. Three years.
Dr d’Udekem. It was actually 2.3 years in your article. And the
reason for that is probably because of one of the flaws of your study.
You stopped the follow up at the first intervention, which is a prob
lem, because if you have an early intervention you don’t know
about the outcome of these patients.
In the follow up study of theMelbourne patients that we did with
similar approaches, similar technique, even similar surgeons at
times, we gathered a median time of follow up of 15 years. Approx
imately 15% of the patients who had a definitive repair died after
the repair. The median time to death was 4 years, which means
half of the patients died 4 years after the repair. If your follow up
is approximately 2.5 years, then you may miss half, or who knows,
maybe three quarters of the deaths after repair. And having a study
for which your conclusion is based solely on survival, it’s a very
annoying fact.
Disputes are often due to miscommunication. I think if we want
to progress in that debate of MAPCAs and unifocalization, we have
to clarify some terminology and in particular the term ‘‘unifocaliza
tion.’’ When you go into the lung’s hilum, you dissect a confluent
intrapulmonary artery, and you put a shunt there or you put a tube
that you connect to the RV, I bet that you’re going to call that uni
focalization. I think I would call it rehabilitation of the native PAs. I
think that we all agree that you have to recruit these intrapulmonary
native PAs. But the real question is, what happened to the collateral
arteries that you detach from the aorta and incorporate in that pul
monary arborization?
Do you have an idea of what proportion of patients underwent
translocation of collateral arteries; and if you know that, do you
have angiographic control studies of these translocated collateral
arteries?
Dr Mussa. Well, you remember from our presentation that we
had reintervened on approximately all of our patients. But in terms
of reintervention on the MAPCAs, there weren’t many. Like I said,
only 1 stent and 2 balloons. There were some surgical interventions
of the proximal portions of those, but I don’t know the exact num
bers of those, but we intervened on approximately 30 main PAs.
Dr d’Udekem. I’m afraid it’s difficult to reintervene on a collat
eral if it’s not existent anymore; that’s my concern and why I think
we need to have these angiographic data.
In your conclusion, I quote, you said, ‘‘MAPCAs are there to be
recruited.’’ We thought that was a very firm statement expressed
like that. We have looked at your results, and we thought there
may be some problems with that statement.
First, as I mentioned, the conclusion is based on survival, and
we’re not sure exactly yet about the survival. It may be excellent,
but I think that remains to be demonstrated.
Second, you may want to use more equipoise in the interpreta
tion of your results. For example, if you look at the characteristics
of your patients, by the end of the study you have 50 of 216 patients
left with a palliation. I think that’s an important proportion. You
may as well conclude in your study that you achieve a good survival
in these patients if you leave a lot of them palliated. Or if you have
only collateral translocations in, I don’t know, 5060 patients, whichgery c December 2009
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rehabilitated native PAs. Obviously these are just suggestions.
I’m wondering if these patients are not sicker than they appear to
be, and, especially about what you say, they have a high rate of in
tervention, 80% reintervention at 5 years. So I’m sure you don’t do
unnecessary reintervention. So one can suspect that a lot of these
patients may have elevated right ventricular to left ventricular pres
sure ratio, and I think that question should be solved.
There were angiographies for every single one of those undergo
ing these 196 reinterventions. It is difficult to show that translocated
collateral arteries disappear. It might be much easier to demonstrate
angiographically that these translocated collateral arteries remain
patent. So if that is the case, it should be relatively easy to show an
giograms with beautiful pulmonary arborization after translocation
of the collateral arteries.
Do you have further data analysis or further evidence, particu
larly angiographic, to substantiate the statement that ‘‘MAPCAs
are there to be recruited,’’ or do you want to soften up a little bit
that statement?
Dr Mussa. I’ll start with the RV LV pressure ratio that you
asked about first. Certainly that’s an excellent question. It’s data
that we are looking at, and we have yet to come to a conclusion
as to what our RV LV pressure ratios are doing over time.
In terms of angiographic follow up to examine the MAPCAs
that we have recruited, unfortunately, a lot of our patients are lo
cated all over Europe, and it’s difficult to get angiographic data
on all of those patients to see exactly how those MAPCAs have
fared over time. So I’m sorry, we don’t have that data.
Dr Frank Hanley (Stanford, Calif). Congratulations on a phe
nomenal series of patients. Just to weigh in on this question of
whether MAPCAs are valuable or not, we have an approximateThe Journal of Thoracic and Car21% incidence of completely absent intrapericardial PAs, meaning
not a string like, not even a cord like structure, but completely ab
sent, including absence of confluent hilar areas. That 21% inci
dence translates into more than 100 patients with unifocalized
vessels and no intrapericardial PAs. With 8 year mean follow up,
and follow up up to 15 years, that subgroup is no different than
the larger population. So it doesn’t play out as a risk factor for either
RV LV pressure ratio or survival.
The important message is, if patients can survive up to 15 years
after unifocalization and repair when there were no true PAs, only
collaterals, with the same outcome as those who have true PAs, it is
unequivocal that collaterals are of value. This is the case when there
are absent PAs. It follows that collaterals will be of benefit in any
case where the PAs, if present, do not arborize normally.
Dr Mussa. Thank you.
Dr James Tweddell (Milwaukee, Wis). Among the patients who
were unifocalized and in whom the VSD was left open, you used 2
strategies to supply pulmonary blood flow, an RV PA conduit or
a Blalock Taussig shunt. How did you make that decision? And
within that group, did you notice any difference in the likelihood
of subsequent VSD closure between those 2 strategies?
Dr Mussa. First, I would just say that of those patients with the
VSD left open and the use of the Blalock Taussig shunt, the use of
shunts was largely historical in this series and was performed early
on more than now. Can I just get your second question again,
please?
Dr Tweddell. Among those 2 strategies of supplying pulmonary
blood flow in the patients whose VSDs were open, did you identify
a difference in the likelihood of subsequent VSD closure between
those 2 strategies?
Dr Mussa. The simple answer is no, we didn’t.diovascular Surgery c Volume 138, Number 6 1275
TABLE E1. Single-factor survival analysis for years to intervention,
death, or end of follow-up
Factor OR 95% CI P value
Age at surgery y 0.95 0.9–1.00 .05
Gender Male vs female 1.01 0.71–1.45 .93
DiGeorge Yes vs no 1.28 0.76–2.18 .35
Previous intervention
at other center
Yes vs no 0.64 0.26–1.58 .33
Previous shunt Yes vs no 1.16 0.78–1.74 .46
Previous recruitment Yes vs no 1.02 0.63–1.66 .94
RV-PA conduit Yes vs no 1.00 0.63–1.60 .99
VSD by conduit Open/conduit vs open 1.27 0.60–2.71 .53
Closed/conduit vs
open
0.93 0.56–1.54 .77
One stage 1 vs multistage 0.90 0.63–1.29 .56
VSD closed Closed vs open 0.85 0.56–1.29 .56
VSD by stage Closed/multi vs open 1.12 0.69–1.82 .65
Closed/1 stage vs open 0.73 0.47–1.15 .18
Group Confluent
intrapulmonary
vs confluent
intrapericardial
1.10 0.73–1.68 .63
Nonconfluent
intrapulmonary
vs confluent
intrapericardial
1.68 1.03–2.73 .04
OR, Odds ratio; CI, confidence interval; VSD, ventricular septal defect; RV-PA, right
ventricle-pulmonary artery. Only age at surgery was selected for multifactor analysis
in stepwise Cox proportional hazards regression; thus, these data are not shown. The
other factors did not add extra association at the P< .05 level.
TABLE E2. Catheter reinterventions (n ¼ 196)
n
Pulmonary artery balloon dilatation 145
Pulmonary artery stent 11
MAPCA balloon dilatation 2
MAPCA stent 1
MAPCA embolization 12
Balloon dilatation conduit 2
Pacemaker 5
Stenting of systemic-pulmonary shunt 1
Dilatation of fenestrated VSD patch 1
MAPCA, Major aortopulmonary collateral arteries; VSD, ventricular septal defect.
TABLE E3. Individual components of surgical reoperations (n ¼ 60)
n
RV-PA conduit change 35
PA augmentation 30
VSD closure 54
Further MAPCA recruitment 3
Pulmonary artery band 2
Resection of obstructive
infundibular muscle bar
1
Repair of RV-PA conduit
false aneurysm
1
RV-PA, Right ventricle-pulmonary artery; VSD, ventricular septal defect; MAPCA,
major aortopulmonary collateral arteries.
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